NF1 c.6097G>A ;(p.D2033N)

Variant ID: 17-29663441-G-A

NM_001042492.2(NF1):c.6097G>A;(p.D2033N)

This variant was identified in 8 publications

View GRCh38 version.




Publications:


Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer.

Molecular Biomedicine
Wang, Zixi Z; Xing, Yurou Y; Li, Bingjie B; Li, Xiaoyu X; Liu, Bin B; Wang, Yongsheng Y
Publication Date: 2022-12-12

Variant appearance in text: NF1: D2033N
PubMed Link: 36508072
Variant Present in the following documents:
  • Main text
  • 43556_2022_Article_107.pdf
View BVdb publication page



Systematic review and meta-analysis of genomic alterations in acral melanoma.

Pigment Cell & Melanoma Research
Broit, Natasa N; Johansson, Peter A PA; Rodgers, Chloe B CB; Walpole, Sebastian T ST; Hayward, Nicholas K NK; Pritchard, Antonia L AL
Publication Date: 2022-05

Variant appearance in text: NF1: D2033N
PubMed Link: 35229492
Variant Present in the following documents:
  • PCMR-35-369-s003.xlsx, sheet 12
View BVdb publication page



Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Lin, Jessica J JJ; Choudhury, Noura J NJ; Yoda, Satoshi S; Zhu, Viola W VW; Johnson, Ted W TW; Sakhtemani, Ramin R; Dagogo-Jack, Ibiayi I; Digumarthy, Subba R SR; Lee, Charlotte C; Do, Andrew A; Peterson, Jennifer J; Prutisto-Chang, Kylie K; Malik, Wafa W; Hubbeling, Harper G HG; Langenbucher, Adam A; Schoenfeld, Adam J AJ; Falcon, Christina J CJ; Temel, Jennifer S JS; Sequist, Lecia V LV; Yeap, Beow Y BY; Lennerz, Jochen K JK; Shaw, Alice T AT; Lawrence, Michael S MS; Ou, Sai-Hong Ignatius SI; Hata, Aaron N AN; Drilon, Alexander A; Gainor, Justin F JF
Publication Date: 2021-05-15

Variant appearance in text: NF1: D2033N
PubMed Link: 33685866
Variant Present in the following documents:
  • Main text
View BVdb publication page



Acquired MET D1228N Mutations Mediate Crizotinib Resistance in Lung Adenocarcinoma with ROS1 Fusion: A Case Report.

The Oncologist
Wang, Yu Y; Chen, Zheng Z; Han, Xiao X; Li, Jiamei J; Guo, Honglin H; Shi, Junping J
Publication Date: 2021-03

Variant appearance in text: NF1: D2033N
PubMed Link: 33000474
Variant Present in the following documents:
  • Main text
View BVdb publication page



ROS1-dependent cancers - biology, diagnostics and therapeutics.

Nature Reviews. Clinical Oncology
Drilon, Alexander A; Jenkins, Chelsea C; Iyer, Sudarshan S; Schoenfeld, Adam A; Keddy, Clare C; Davare, Monika A MA
Publication Date: 2021-01

Variant appearance in text: NF1: D2033N
PubMed Link: 32760015
Variant Present in the following documents:
  • Main text
View BVdb publication page



MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Sato, Hiroki H; Schoenfeld, Adam J AJ; Siau, Evan E; Lu, Yue Christine YC; Tai, Huichun H; Suzawa, Ken K; Kubota, Daisuke D; Lui, Allan J W AJW; Qeriqi, Besnik B; Mattar, Marissa M; Offin, Michael M; Sakaguchi, Masakiyo M; Toyooka, Shinichi S; Drilon, Alexander A; Rosen, Neal X NX; Kris, Mark G MG; Solit, David D; De Stanchina, Elisa E; Davare, Monika A MA; Riely, Gregory J GJ; Ladanyi, Marc M; Somwar, Romel R
Publication Date: 2020-06-15

Variant appearance in text: NF1: D2033N
PubMed Link: 32122926
Variant Present in the following documents:
  • Main text
View BVdb publication page



Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
McCoach, Caroline E CE; Le, Anh T AT; Gowan, Katherine K; Jones, Kenneth K; Schubert, Laura L; Doak, Andrea A; Estrada-Bernal, Adriana A; Davies, Kurtis D KD; Merrick, Daniel T DT; Bunn, Paul A PA; Purcell, W Tom WT; Dziadziuszko, Rafal R; Varella-Garcia, Marileila M; Aisner, Dara L DL; Camidge, D Ross DR; Doebele, Robert C RC
Publication Date: 2018-07-15

Variant appearance in text: NF1: D2033N
PubMed Link: 29636358
Variant Present in the following documents:
  • Main text
View BVdb publication page



Resisting Resistance: Targeted Therapies in Lung Cancer.

Trends In Cancer
Lin, Jessica J JJ; Shaw, Alice T AT
Publication Date: 2016-07

Variant appearance in text: NF1: D2033N
PubMed Link: 27819059
Variant Present in the following documents:
  • Main text
View BVdb publication page